UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
This article explains practical timing for rebalancing index funds in retirement, helping you maintain targets and smooth withdrawals.
15,959 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Plug Power stock popped after-hours following a strong Q4 showing and raised 2026 guidance. This article breaks down ...
DraftKings is diversifying beyond its core betting business. This article examines what that shift could mean for inv...
As accel acel 2025 earnings loom, investors seek clarity on revenue, margins, and guidance. This guide breaks down wh...
A Switzerland-registered firm launches the $BANK token on Solana, offering on-chain exposure to a professionally mana...
A fashion brand founder downsizes a high-revenue operation to pursue profitability, exemplifying a growing trend amon...
As Verastem prepares for its 2025 earnings outlook, investors should focus on cash runway, collaboration milestones, ...
Stratasys has long been a trailblazer in 3D printing, but the road ahead is proving tougher amid competition and cost...
Cathie Wood Goes Bargain highlights how Ark Invest’s founder targets beaten-down growth bets for long-term gains. Her...
Defense orders for long-range artillery systems reshaping modern warfare are driving a fresh wave of investor interes...
The AI hype is undeniable, but investors want answers: is this a bubble about burst just or the start of a longer asc...
FuelCell Energy stock just dropped after a mixed Q1 2026 report. In this analysis, we break down the what, why, and w...